Day: May 11, 2023

Revenue up 28% from Q4 2022 Gross profit up 60% from Q4 2022 Positive adjusted EBITDA and cash flow from continuing operations $7.6 million of cash, restricted cash and investmentsMINNETONKA, Minn., May 11, 2023 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (NASDAQ: PEGY), a leading provider of sustainable solar energy and back-up power to households and small businesses, today announced financial results for the first quarter ended March 31, 2023. Pineapple CEO Kyle Udseth commented, “The strength of our Q1 results – the first full quarter with SUNation in the fold – showcases the value of our acquisition strategy and demonstrates our ability to execute operationally in integrating our businesses and driving accelerated performance. We’re ahead of schedule on our organic growth initiatives, and more importantly we reached the critical...

Q2’23 Revenue Increased 37% to $16.1M with Positive Operating Income of $0.4M Gross Margin up 1360 Basis Points to 46% in Q2’23 Management to Host Conference Call Today at 5:00 p.m. ET Brooklyn, NY, May 11, 2023 (GLOBE NEWSWIRE) —  Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, has reported its financial and operational results for the second quarter ended March 31, 2023. Key Second Quarter FY 2023 and Subsequent HighlightsRevenue for Q2’23 increased 37% to $16.1 million, compared to revenue of $11.7 million for Q2’22.Security segment revenues increased 47% to $9.9m in Q2’23 as border protection vertical drives new order volumes for Vicon.Gross margin up 1360 basis points to 46% in Q2’23 from 32% in the prior year quarter Operating income of $0.4 million for Q2’23 compared...

VALENCIA, Calif. and MELBOURNE, Australia, May 11, 2023 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today reported financial results for the first quarter March 31, 2023. Financial Highlights and Recent UpdatesCommercial revenue, which excludes BARDA revenue, of $10.5 million, a 40% increase compared to $7.4 million for the same period in 2022 Total revenue, which includes BARDA revenue, of $10.6 million, a 40% increase compared to $7.5 million for the same period in 2022 Gross profit margin was 84% compared to 76% in the same period in 2022 Expanded field sales organization from 30 to 69, towards our goal of 70 Automated disaggregation...

Phase 1 Study of Novel, Highly Selective CDK9 Inhibitor GFH009 Successfully Completed for Patients with Acute Myeloid Leukemia; 94% of Patients Enrolled to Date Alive and Durable Remission in Patient with Acute Myeloid Leukemia > 6 months Phase 3 REGAL Study of Galinpepimut-S in Patients with Acute Myeloid Leukemia on Track for Interim Analysis by Late 2023/Early 2024 NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today provided a business update and reported its financial results for the quarter ended March 31, 2023. “We are pleased with the continued advancement of both our galinpepimut-S (GPS) and GFH009 clinical programs...

Presented initial preclinical data from ETX-123, Eliem’s lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed mechanism of action on neuronal excitability Additional preclinical data updates for ETX-123 expected in 2023 SEATTLE and CAMBRIDGE, United Kingdom, May 11, 2023 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq: ELYM), a biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems, today provided a business update and reported financial results for the quarter ended March 31, 2023. “We were excited to share our initial preclinical data from ETX-123, our lead candidate in the Kv7 program, during the first quarter,”...

– Continued Commercial Momentum Within Core Cannabinoid Markets – – Recent Commercial Launches of Colombian Dry Flower Exports to Australia and Germany Mark Key Operational Milestone – – Continuing Cost Reduction Measures Drive Leaner Operational Infrastructure – – Reiterating Previously Issued 2023 Outlook – TOCANCIPÁ, Colombia, May 11, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is reporting financial and operating results for the first quarter ended March 31, 2023. All financial information is provided in US dollars unless otherwise indicated. “Our first quarter performance reflects the progress we are making on our key growth objectives, including our focused commercial strategy,...

First Quarter Revenues Increased 17% to $42.1 millionFirst Quarter Gross Margin Expanded to 54% First Quarter Net Loss Attributable to UpHealth, Inc. Decreased 54% to $8.1 millionFirst Quarter Adjusted EBITDA Improved by $7.9 million to $6.6 million Announced Strategic Sale of Innovations Group, Inc. for $56.0 million DELRAY BEACH, Fla., May 11, 2023 (GLOBE NEWSWIRE) — UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the first quarter ended March 31, 2023. UpHealth Chief Executive Officer Sam Meckey said, “I am very proud of our team’s efforts which contributed to our top line growth of 17% to $42.1 million in the first quarter of 2023 over...

NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) — Getty Images Holdings, Inc. (“Getty Images” or the “Company”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported financial results for the first quarter ended March 31, 2023. “We are pleased to report a quarter of revenue growth, all of which is organic, despite foreign exchange pressures, driven by strong subscription growth, subscription renewal rates, new customer growth and increased consumption of our content,” said Craig Peters, Chief Executive Officer of Getty Images. “The increased customer commitment and consumption is underpinned by the uniqueness and quality of our content offerings. We are focused on expanding this differentiation alongside embracing new capabilities to increase the value we provide to our customers and create new and recurring...